📌 A major milestone update: Our Lady of the Lake Regional Medical Center has now screened 5000 patients with the IntelliSep sepsis test since implementation in August 2023— leading to significant improvements in recognition, time to treatment, and overall patient outcomes. Hear from an Our Lady of the Lake Regional Medical Center patient, Terri White, who was flagged as high-risk for sepsis within minutes of taking the IntelliSep test within the ED, and immediately “pulled out of the waiting room” and admitted for treatment. “When I was told that I had sepsis, I was shocked, and also scared, because I didn’t realize I was so sick. It was a miracle that I went to Our Lady of the Lake Regional Medical Center instead of another hospital, because I might not be alive today if I had not walked through their doors,” recalled Terri. 👉 Learn more about the impact of IntelliSep here: https://lnkd.in/g5htgUik #Sepsis #PatientImpact
Cytovale
Biotechnology Research
San Francisco, CA 12,184 followers
At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.
About us
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale Subscribe to our newsletter: http://eepurl.com/huCdiH
- Website
-
https://cytovale.com
External link for Cytovale
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Francisco, CA
- Type
- Privately Held
- Founded
- 2013
- Specialties
- medical device
Locations
-
Primary
150 Executive Park Blvd
San Francisco, CA 94134, US
Employees at Cytovale
-
Lindy Morris Fishburne
Managing Partner, Breakout Ventures
-
Angela Williams
Director, People & Culture, MA Organizational Leadership- Cytovale
-
Bob Holliday, MBA
Global Learning & Development Executive | Talent Management | Leadership Development | Veteran | Change Management | Published Author | Strategic…
-
Nicola Staudinger MSN BSN RN CEN
Senior Clinical Consultant
Updates
-
Check out this Kevin MD podcast interview with Cytovale's Senior Physician Advisor, Robert Scoggins, MD, PhD on 'Using technology to diagnose sepsis.' Learn how the implementation of a host response technology in a protocolized fashion would support your ED with early sepsis detection.
-
#DYK: As many as 80% of septic shock patients can be saved with rapid diagnosis and treatment? Learn how the IntelliSep sepsis test may aid in the early detection and faster treatment of potentially septic patients in your facility from the experience of a site that implemented the test in their ED protocol. https://lnkd.in/gMdNZejd #EMCCM #EmergencyMedicine
-
-
Check out this video of Terri White, a patient who was tested with IntelliSep at Our Lady of the Lake Regional Medical Center, as she reflects on her sepsis journey. Terri checked into Our Lady of the Lake Regional Medical Center after experiencing debilitating symptoms. Within minutes of taking the IntelliSep test, she was flagged by the ED staff as being high-risk for sepsis and immediately “pulled out of the waiting room” and admitted for treatment. #SepsisSurvivor #IntelliSep #SepsisTest
"Why would you go anywhere else?" Meet Terri White, a sepsis survivor whose life was saved by the Intellisep test and expert emergency care only available at Our Lady of the Lake Regional Medical Center. Read about Terri's sepsis journey: https://bit.ly/3VAhJQk
-
A chance interaction on a plane led to a clinical partnership that is now transforming sepsis care. Here is a throwback to ‘The Doctor Will Hear You Now’ podcast featuring Dr. Hollis O’Neal and Dr. Christopher Thomas where they discuss how it all started. https://lnkd.in/gVUjNrvQ #TransformingCare #EndSepsis
-
-
Many patients do not exhibit the usual signs and symptoms of sepsis at ED triage, which can lead to delayed diagnosis and increased mortality. Learn how IntelliSep rapidly identifies these occult sepsis cases by checking out this Distinguished Abstract Award-winning poster at #ADLM2024: ‘Expediting Identification of Occult Sepsis with a Novel Diagnostic for Patients Presenting to the ED with Possible Infection’. Date: July 31, 2024 Time: 9:30 AM - 5:00 PM Local Time Location: Poster Hall Learn more: https://bit.ly/3RwPHEg #AwardWinner #SepsisResearch
-
-
Since August 2023, Our Lady of the Lake Regional Medical Center has used the IntelliSep sepsis test as part of their ED sepsis protocol, leading to improved patient care, reduced length of stay and $1,429 cost savings on average per patient tested with IntelliSep. Click here to learn how Our Lady of the Lake Regional Medical Center is setting a gold standard in sepsis care: https://bit.ly/4b2Dy0D
-
-
Attending #ADLM2024 in July? Stop by the Cytovale Booth# 4819 for Cytovale System demonstrations and to learn how the ~8-minute IntelliSep sepsis test empowers laboratory professionals to accelerate sepsis detection and care in Emergency Departments. Register for ADLM here: https://lnkd.in/gntuQnNH
-
-
Ever wondered about the technology behind the Cytovale System that allows IntelliSep to provide clinicians with sepsis probability in ~8 minutes? Learn more about what powers Cytovale System via this article from Phantom and Medical Design Briefs: https://bit.ly/3VFDoIl
-
-
Confidently rule-out sepsis with IntelliSep. A recent peer-reviewed study analyzing 1000 adult ED patients with signs or suspicion of infection demonstrated that IntelliSep has 98% NPV for sepsis—which may allow care teams to explore alternative diagnoses in low-risk patients. Access the Academic Emergency Medicine article here to learn more: https://lnkd.in/gsevVKfD #EMResearch #EmergencyCare #SepsisManagement
-